B. Purandare

发表

β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.

Jian Zhang, Longmei Zhao, B. Hantash, 2013, Human immunology.

Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cells.

Longmei Zhao, B. Hantash, T. Teklemariam, 2014, Biochemical and biophysical research communications.

Temporal HLA profiling and immunomodulatory effects of human adult bone marrow- and adipose-derived mesenchymal stem cells.

Longmei Zhao, B. Hantash, T. Teklemariam, 2014, Regenerative medicine.

Non-viral precision T cell receptor replacement for personalized cell therapy

Katie M. Campbell, D. Baltimore, J. Sosman, 2022, Nature.

TESTING SEVERITY OF THE DISEASES CAUSED BY PATHOGEN

B. Purandare, P. Shingare, 2018 .

Neoantigen-targeted CD8^+ T cell responses with PD-1 blockade therapy

O. Griffith, M. Griffith, A. Ribas, 2023, Nature.

Abstract 4783: Highly efficient, non-viral precision genome engineering for the generation of personalized neoepitope-specific adoptive T cell therapies

B. Sennino, S. Mandl, A. Litterman, 2019, Experimental and Molecular Therapeutics.

Abstract 1433: NeoTCR-P1, a novel neoepitope-specific adoptive cell therapy, consists of T cells with ‘younger’ phenotypes that rapidly proliferate and kill target cells upon recognition of cognate antigen

B. Sennino, S. Mandl, A. Litterman, 2019, Clinical Research (Excluding Clinical Trials).

Abstract 1435: An ultra-sensitive and high-throughput technology (imPACT) for the identification and isolation of intrinsic and emergent neoepitope-specific T cells from the peripheral blood and TILs of cancer patients

B. Sennino, S. Mandl, Salemiz Sandoval, 2019, Clinical Research (Excluding Clinical Trials).

Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

A. Becker, J. Powers, A. Udyavar, 2022, Molecular cancer therapeutics.

Differential expression of stem cell markers in human follicular bulge and interfollicular epidermal compartments

Longmei Zhao, B. Hantash, Shu Jiang, 2010, Histochemistry and Cell Biology.

1478 A phase I study of personalized adoptive TCR T cell therapy in patients with solid tumors: safety, efficacy, and T cell trafficking to tumors of non-virally gene edited T cells

D. Baltimore, J. Sosman, A. Ribas, 2022, Late-Breaking Abstracts.